Alterity Therapeutics Limited

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Alterity Therapeutics Limited
Former names: Prana Biotechnology Ltd
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Australia
Headquarters city: Melbourne
Headquarters country: Australia
Fiscal year end: June
Ticker symbol: ATHE
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001131343

Board of directors

Follow this board

Ann Michelle Cunningham · Director
Since 2026
David Allen Stamler · Director · Chief Executive Officer
Since 2026
Julian Michael Babarczy · Director
Since 2026
Lawrence Bernard Gozlan · Director
Since 2026
Peter Ashley Marks · Director
Since 2026

Chief executives

David Allen Stamler · Chief Executive Officer

Since April 2026

Board connections

1 of this board's directors also sit on 1 other board. 1 is in the same sector.

Shared director Other board Same sector

Vistagen Therapeutics Inc. Same sector
via Ann Michelle Cunningham

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $23,810; 1 purchase by 1 insider
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Aug 31, 2026	Peter Ashley Marks Director	Open-market purchase	+47,620	$0.50	$23,810

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization AC Immune SA Nasdaq: ACIU · 1015 Lausanne, Switzerland Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization

Questions about Alterity Therapeutics Limited

Who is the CEO of Alterity Therapeutics Limited?

David Allen Stamler has been Alterity Therapeutics Limited's Chief Executive Officer since April 2026.

How many directors are on Alterity Therapeutics Limited's board?

Alterity Therapeutics Limited's board has 5 directors: Ann Michelle Cunningham, David Allen Stamler, Julian Michael Babarczy, Lawrence Bernard Gozlan and Peter Ashley Marks.

Are Alterity Therapeutics Limited insiders buying or selling shares?

Over the last 12 months, Alterity Therapeutics Limited insiders bought $23,810 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Alterity Therapeutics Limited connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="alterity-therapeutics-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.